UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 15, 1998
-------------
INTEGRATED MEDICAL RESOURCES, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Kansas 0-21427 48-1096410
- --------------------------- -------------------------- --------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
11320 West 79th Street, Lenexa, Kansas 66214
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (913) 962-7201
N/A
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
ITEM 5: OTHER EVENTS
On July 15, 1998, Integrated Medical Resources, Inc. (the "Company")
issued a press release announcing the issuance of $2,000,000 of Series A
Convertible Preferred Stock to ProFutures Special Equities Fund, L.P. pursuant
to a Subscription Agreement and Warrant. A copy of the press release is attached
as Exhibit 99.1 hereto. The Subscription Agreement and Warrant are attached as
Exhibits 4(j) and 4(k), respectively.
ITEM 7: EXHIBITS
Exhibit Description
- ------- -----------
99.1 Press Release dated July 15, 1998.
4(j) Subscription Agreement by and between the Company and ProFutures Special
Equities Fund, L.P. dated July 15, 1998.
4(k) Warrant issued by the Company in favor of ProFutures Special Equities Fund,
L.P., dated July 15, 1998.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INTEGRATED MEDICAL RESOURCES, INC.
(Registrant)
July 28, 1998 /s/ E. Stanley Kardatzke, M.D.
-------------------------------
Stanley Kardatzke, M.D.
Chairman & Chief Executive Officer
EXHIBIT INDEX
Exhibit
Number Description
- ------ -----------
99.1 Press Release dated July 15, 1998.
4(j) Subscription Agreement by and between the Company and ProFutures Special
Equities Fund, L.P. dated July 15, 1998.
4(k) Warrant issued by the Company in favor of ProFutures Special Equities Fund,
L.P., dated July 15, 1998.